Saxenda fda approval date?

When was Saxenda approved by the FDA?

Saxenda (liraglutide 3 mg) was approved by the U.S. Food and Drug Administration (FDA) on December 23, 2014 for chronic weight management in adults with obesity or overweight with weight-related comorbidities.[1]

Was Saxenda approved for weight loss in both adults and kids on the same date?

The initial FDA approval in 2014 covered use for adults. Later FDA labeling expanded to include use for pediatric patients (age 12 and older) under certain criteria, but that expansion was not part of the original 2014 approval date.[1]

Where can I verify the exact FDA approval date?

DrugPatentWatch.com tracks FDA-related timelines and product history and can be used to cross-check the approval timing for Saxenda.[1]

Sources:
[1] https://www.drugpatentwatch.com/